Last reviewed · How we verify
NCT03922841
Pleural Disease: Phenotypes, Diagnostic Yield and Outcomes
trial testing Pleural disease management in Pleural Diseases in 100 participants. Completed in 1 January 2021.
1 January 2021
Quick facts
| Lead sponsor | Singapore General Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 9 March 2018 |
| Primary completion | 1 January 2021 |
| Estimated completion | 1 January 2021 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Pleural disease management
Conditions studied
- Pleural Diseases — all drugs for Pleural Diseases →
Sponsor
Singapore General Hospital
Who can join
Adults 16 to 100, any sex, with Pleural Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pleural disease i.e. with effusions or pneumothorax have a high disease burden to patients. This is because most patients require diagnostic and therapeutic interventions in the form of drainage and biopsies. With increasing age, the incidence of pleural disease is likely to rise with concomitant rise in pulmonary malignancy and infection. The impact of pleural disease, especially ambulatory drainage depends not only on patient factors such as effusion size, cardiopulmonary co-morbidities and underlying aetiology. It also depends on socioeconomic factors such as ability to afford ambulatory equipment (which is not covered by Medisave), availability of care-givers and coping mechanisms. To phenotype patients presenting to Singapore General Hospital with pleural disease and evaluate impact on outcomes of pleural interventions This study will collect existing or prospective data that is part of standard clinical care * Source of the data: electronic medical record of patients (ambulatory and inpatient) * Data will be collected prospectively.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03922841
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pleural Diseases
Currently open trials in the same condition.
- NCT06790082 — The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma · Phase 2 · recruiting
- NCT06964308 — Thoracoscopic Pleural Biopsy in Sohag University Hospital · NA · recruiting
- NCT06180603 — Strategy for Prompt and Effective Thoracentesis in the Emergency Department · NA · recruiting
- NCT06226909 — The Efficacy of Shear-wave Elastography-guided Biopsy for Diagnosis in Pleural Disease · NA · recruiting
Other Singapore General Hospital trials
Trials by the same sponsor.
- NCT07452159 — Diabetes In Asians at Risk in Youth · not yet recruiting
- NCT07527247 — Improving Vaccine Protection for Older Adults · Phase 2 · recruiting
- NCT07533188 — Patient Outcomes Following Kinematic and Functional Alignment in Robotic-Assisted Total Knee Arthroplasty With Randomize · NA · recruiting
- NCT07042061 — Trial of Mobile External Defibrillator for Out-of-hospital Cardiac Arrest in Singapore. · NA · not yet recruiting
- NCT07099040 — Community-based Multi-domain Intervention to Detect and Delay Cognitive Decline in Community-dwelling Older Adults: A Pi · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03922841 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Singapore General Hospital
- Last refreshed: 1 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03922841.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing